BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16845287)

  • 21. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Pung L; Ahmad M; Mueller K; Rosenberg J; Stave C; Hwang GL; Shah R; Kothary N
    J Vasc Interv Radiol; 2017 Mar; 28(3):334-341. PubMed ID: 28109724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
    Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
    J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
    Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
    Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluating efficacy of transcatheter arterial chemo-embolization combined with radiofrequency ablation on patients with hepatocellular carcinoma by 18FDG-PET/CT].
    Zhao M; Wu PH; Zeng YX; Zhang FJ; Huang JH; Fan WJ; Gu YK; Zhang L; Tan ZB; Lin YE
    Ai Zheng; 2005 Sep; 24(9):1118-23. PubMed ID: 16159437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation.
    Ashoori N; Bamberg F; Paprottka P; Rentsch M; Kolligs FT; Siegert S; Peporte A; Al-Tubaikh JA; D'Anastasi M; Hoffmann RT; Reiser MF; Jakobs TF
    Digestion; 2012; 86(4):338-48. PubMed ID: 23207185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cone-Beam CT-Guided Chemoembolization in Patients with Complete Response after Previous Chemoembolization but Subsequent Elevated α-Fetoprotein without Overt Hepatocellular Carcinoma.
    Wattanasatesiri T; Kim HC; Choi JW; Lee JH; Joo I; Hur S; Lee M; Jae HJ; Chung JW
    J Vasc Interv Radiol; 2019 Aug; 30(8):1273-1280. PubMed ID: 31235410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation.
    Yamagami T; Yoshimatsu R; Ishikawa M; Kajiwara K; Aikata H; Tashiro H; Kakizawa H; Toyoda N; Ohdan H; Awai K
    Hepatogastroenterology; 2014; 61(133):1387-92. PubMed ID: 25436316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation.
    Alba E; Valls C; Dominguez J; Martinez L; Escalante E; Lladó L; Serrano T
    AJR Am J Roentgenol; 2008 May; 190(5):1341-8. PubMed ID: 18430853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.